Phibro Animal Health (NASDAQ:PAHC) Shares Gap Up - What's Next?

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report)'s share price gapped up prior to trading on Monday . The stock had previously closed at $28.00, but opened at $29.63. Phibro Animal Health shares last traded at $29.99, with a volume of 61,889 shares.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on PAHC shares. BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target on the stock in a report on Monday, June 16th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and boosted their target price for the stock from $25.00 to $35.00 in a report on Monday. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Morgan Stanley set a $26.00 target price on shares of Phibro Animal Health and gave the company an "equal weight" rating in a research report on Wednesday, June 25th. Finally, Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $24.40.

Phibro Animal Health Price Performance

The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67. The company has a market capitalization of $1.26 billion, a P/E ratio of 39.89, a P/E/G ratio of 0.50 and a beta of 0.75. The business's fifty day moving average price is $23.83 and its 200-day moving average price is $22.19.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. The business had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million. As a group, sell-side analysts predict that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 1.54%. Phibro Animal Health's payout ratio is presently 61.54%.

Hedge Funds Weigh In On Phibro Animal Health

Several institutional investors and hedge funds have recently modified their holdings of PAHC. Man Group plc bought a new stake in Phibro Animal Health in the 4th quarter worth about $501,000. GAMMA Investing LLC lifted its position in shares of Phibro Animal Health by 2,011.4% during the 1st quarter. GAMMA Investing LLC now owns 36,718 shares of the company's stock valued at $784,000 after buying an additional 34,979 shares in the last quarter. Lazard Asset Management LLC lifted its position in shares of Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after buying an additional 1,589 shares in the last quarter. Nuveen Asset Management LLC increased its stake in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after acquiring an additional 103,618 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Phibro Animal Health by 37.1% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 62,566 shares of the company's stock worth $1,314,000 after acquiring an additional 16,917 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.